These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1654317)

  • 41. Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics.
    Breimer DD
    Br J Clin Pharmacol; 1979; 8(1):7S-13S. PubMed ID: 41545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Excretion of quazepam into human breast milk.
    Hilbert JM; Gural RP; Symchowicz S; Zampaglione N
    J Clin Pharmacol; 1984 Oct; 24(10):457-62. PubMed ID: 6150944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Classification of benzodiazepine hypnotics in humans based on receptor occupancy theory.
    Ito K; Yamada Y; Nakamura K; Sawada Y; Iga T
    J Pharmacokinet Biopharm; 1993 Feb; 21(1):31-41. PubMed ID: 8410682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel receptor specificity of selected benzodiazepines.
    Barnett A; Iorio LC; Billard W
    Clin Neuropharmacol; 1985; 8 Suppl 1():S8-16. PubMed ID: 3017550
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat.
    Lister RG; Greenblatt DJ; Abernethy DR; File SE
    Brain Res; 1984 Jan; 290(1):183-6. PubMed ID: 6419985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liquid chromatographic assay and pharmacokinetics of quazepam and its metabolites following sublingual administration of quazepam.
    Gupta SK; Ellinwood EH
    Pharm Res; 1988 Jun; 5(6):365-8. PubMed ID: 3244647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Introduction to the pharmacokinetics and pharmacodynamics of benzodiazepines.
    McKenzie SG
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):623-7. PubMed ID: 6141605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A guide to benzodiazepine selection. Part I: Pharmacological aspects.
    Teboul E; Chouinard G
    Can J Psychiatry; 1990 Nov; 35(8):700-10. PubMed ID: 1980860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationships between CSF drug concentrations, receptor binding characteristics, and pharmacokinetic and pharmacodynamic properties of selected 1,4-substituted benzodiazepines.
    Colburn WA; Jack ML
    Clin Pharmacokinet; 1987 Sep; 13(3):179-90. PubMed ID: 2822333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of benzodiazepine brain uptake: lipophilicity versus binding affinity.
    Arendt RM; Greenblatt DJ; Liebisch DC; Luu MD; Paul SM
    Psychopharmacology (Berl); 1987; 93(1):72-6. PubMed ID: 2888155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationships of brain and plasma levels of quazepam, flurazepam, and their metabolites with pharmacological activity in mice.
    Hilbert JM; Iorio L; Moritzen V; Barnett A; Symchowicz S; Zampaglione N
    Life Sci; 1986 Jul; 39(2):161-8. PubMed ID: 3724367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New benzodiazepines for sedation.
    Cornett EM; Novitch MB; Brunk AJ; Davidson KS; Menard BL; Urman RD; Kaye AD
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):149-164. PubMed ID: 30322456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma quantification of quazepam and its 2-oxo and N-desmethyl metabolites by capillary gas chromatography.
    Bun H; Coassolo P; Ba B; Aubert C; Cano JP
    J Chromatogr; 1986 May; 378(1):137-45. PubMed ID: 3733966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurochemical and pharmacokinetic correlates of the clinical action of benzodiazepine hypnotic drugs.
    Greenblatt DJ; Miller LG; Shader RI
    Am J Med; 1990 Mar; 88(3A):18S-24S. PubMed ID: 1968714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single and repeated dose kinetics of the hypnotic agent loprazolam in healthy volunteers.
    Stevens LA; Bevan CD; Salmon J; Krieger J; Perianu M; LeGo A
    Eur J Clin Pharmacol; 1983; 25(5):651-5. PubMed ID: 6319150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacodynamics of benzodiazepines after single oral doses: kinetic and physiochemical correlates.
    Greenblatt DJ; Arendt RM; Shader RI
    Psychopharmacology Suppl; 1984; 1():92-7. PubMed ID: 6147845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Which benzodiazepine, why and how?
    Straughan JL
    S Afr Med J; 1979 Jun; 55(27):1110-4. PubMed ID: 483094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Propranolol does not alter flutoprazepam kinetics and metabolism in the rat.
    Conti I; Sarati S; Caccia S
    Eur J Drug Metab Pharmacokinet; 1991; 16(1):53-8. PubMed ID: 1936062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Metabolism of the New Benzodiazepine Remimazolam.
    Schmalix W; Petersen KU; Pesic M; Stöhr T
    Curr Drug Metab; 2024; 25(2):164-173. PubMed ID: 38523539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Benzodiazepine consumption in Spain.
    Rayón P; Montero D; Santamaría B; Madurga M; De Abajo FJ
    Eur J Clin Pharmacol; 1997; 52(4):321-3. PubMed ID: 9248774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.